FIELD: medicine; veterinary.
SUBSTANCE: invention relates to an agent for treating metabolic syndrome, including adsorbed on solid sorbent such as sorbitol, lactose or starch, at least, one polyprenylphosphate or polyprenylpyrophosphate with number of isoprene links from 7 to 30.
EFFECT: invention provides effective agent for reducing body weight, normalising carbohydrate and lipid metabolism.
6 cl, 1 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR DISSOLUTION OF BILE STONES AND TREATMENT OF CHOLELITHIASIS | 2015 |
|
RU2605264C1 |
REMEDY FOR PREVENTION AND TREATMENT OF METABOLIC SYNDROME | 2022 |
|
RU2806867C1 |
MEDICATION FOR PREVENTION AND TREATMENT OF ACUTE AND CHRONIC PANCREATITIS | 2010 |
|
RU2425669C1 |
BIOLOGICALLY ACTIVE ADDITIVE AND METHOD OF ITS MANUFACTURING | 2010 |
|
RU2427284C1 |
MEDICATION FOR REDUCTION OF HEPATITIS C VIRUS REPRODUCTION | 2013 |
|
RU2526179C1 |
DRUG SUBSTANCE OF POLYPRENYLPHOSPHATES AND BETA-SITOSTEROL AND METHOD FOR PREPARING IT | 2014 |
|
RU2542420C1 |
METHOD OF CORRECTING VAGINAL DYSBIOSIS IN CASE OF METABOLIC SYNDROME | 2012 |
|
RU2484669C1 |
METHOD OF SIMULATING AN INFECTED WOUND IN RATS WITH BACKGROUND OF LONG-TERM CURRENT DIABETES MELLITUS | 2020 |
|
RU2735708C1 |
METHOD TO REGULATE SECRETORY ACTIVITY OF PANCREAS AT EXPERIMENTAL ACUTE PANCREATITIS, METHOD TO REGULATE SECRETORY ACTIVITY OF PANCREAS IN POST-OPERATIVE INTERFERENCE UPON ORGANS OF GASTROHEPATOPANCREATODUODENAL AREA IN AN EXPERIMENT | 1999 |
|
RU2181599C2 |
2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE AND NICOTINIC ACID SALT, HAVING HYPOGLYCEMIC, HYPOLIPIDEMIC AND NEUROPROTECTIVE ACTIVITY AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2454406C2 |
Authors
Dates
2016-04-10—Published
2014-12-11—Filed